Blood spot tests set to replace costly vials

Blood spot tests set to replace costly vials

February 27, 2020

From The Lead South Australia:
Blood testing technology developed by South Australian medical researchers is poised to transform the nutrition industry.

Trajan Nutrition dried blood spot (DBS) card

Trajan Nutrition CEO Marco Baccanti said, “Pathology labs can also now start using this methodology with far less invasive collection of blood of patients and using faster analytics and more cost effective techniques.”

University of Adelaide Professor of Functional Food Science Robert Gibson began work on the technology 10 years ago with Professor Maria Makrides.

“We are one of the leading labs now at developing the new dry blood spot tests for a variety of nutrients and compounds,” Prof Gibson said.

Read the full article: Blood spot tests set to replace costly vials

Trajan Nutrition CEO Marco Baccanti and University of Adelaide Professor of Functional Food Science Robert Gibson.
Trajan Nutrition CEO Marco Baccanti and University of Adelaide Professor of Functional Food Science Robert Gibson.

More information
Trajan Nutrition




Also in News

Trajan and Queen’s University awarded Mitacs grant to develop MES technology for mass spectrometry
Trajan and Queen’s University awarded Mitacs grant to develop MES technology for mass spectrometry

March 03, 2020

Trajan Scientific and Medical and Queen’s University, Kingston, Canada, have been awarded a Mitacs Accelerate grant to develop new multiple electrospray (MES) technologies to increase throughput and sensitivity in mass spectrometry (MS).

Read More

SAHMRI and Trajan Nutrition sign new agreement to accelerate nutrition testing worldwide
SAHMRI and Trajan Nutrition sign new agreement to accelerate nutrition testing worldwide

February 17, 2020

Trajan Nutrition has signed a Memorandum of Understanding with the South Australian Health and Medical Research Institute (SAHMRI) to accelerate the translation in the global market of nutrition testing research led by professors Maria Makrides and Robert Gibson.

Read More

Trajan’s hemaPEN included on TGA’s ARTG as first blood microsampling device for use in Australia
Trajan’s hemaPEN included on TGA’s ARTG as first blood microsampling device for use in Australia

February 07, 2020

Trajan Scientific and Medical’s hemaPEN® device has been included on the Australian Register of Therapeutic Goods (ARTG). The device enables the volumetrically accurate collection and storage of four dried blood spot (DBS) samples remote to the clinical setting, to drive information-rich healthcare decision making.

Read More